Prostaglandins inhibit lipoprotein lipase gene expression in macrophages

J. B. Desanctis, L. Varesio, D. Radzioch

Research output: Contribution to journalArticle

Abstract

In the present investigation of the effects of prostaglandin E2 (PGE2) on lipoprotein lipase (LPL) gene expression in macrophages, we observed that treatment of macrophages with PGE2 increased the levels of adenosine 3',5'- cyclic monophosphate (cAMP), while the addition of exogenous 5-bromo-cAMP to macrophage cultures resulted in down-regulation of LPL expression. Using indomethacin (INDO), an inhibitor of cyclo-oxygenase and prostaglandins production, we determined that PGE2 acts as a feedback inhibitor of LPL expression. We found that inhibited secretion of LPL protein in lipopolysaccharide (LPS)-treated macrophages could be restored to control levels by the addition of INDO to the medium. In contrast, INDO did not reverse the inhibition of LPL mRNA induced by LPS. Overall, our results have demonstrated that PGE2 is a potent inhibitor of LPL gene expression and indicated that its action may play an important physiological role in the regulation of LPL gene expression during bacterial infections.

Original languageEnglish
Pages (from-to)605-610
Number of pages6
JournalImmunology
Volume81
Issue number4
Publication statusPublished - 1994

Fingerprint

Lipoprotein Lipase
Prostaglandins
Macrophages
Gene Expression
Dinoprostone
Indomethacin
Lipopolysaccharides
Cyclooxygenase Inhibitors
Prostaglandin-Endoperoxide Synthases
Bacterial Infections
Cyclic AMP
Down-Regulation
Messenger RNA

ASJC Scopus subject areas

  • Immunology

Cite this

Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. / Desanctis, J. B.; Varesio, L.; Radzioch, D.

In: Immunology, Vol. 81, No. 4, 1994, p. 605-610.

Research output: Contribution to journalArticle

Desanctis, JB, Varesio, L & Radzioch, D 1994, 'Prostaglandins inhibit lipoprotein lipase gene expression in macrophages', Immunology, vol. 81, no. 4, pp. 605-610.
Desanctis, J. B. ; Varesio, L. ; Radzioch, D. / Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. In: Immunology. 1994 ; Vol. 81, No. 4. pp. 605-610.
@article{945801563c7f4b109f025a7c97580d34,
title = "Prostaglandins inhibit lipoprotein lipase gene expression in macrophages",
abstract = "In the present investigation of the effects of prostaglandin E2 (PGE2) on lipoprotein lipase (LPL) gene expression in macrophages, we observed that treatment of macrophages with PGE2 increased the levels of adenosine 3',5'- cyclic monophosphate (cAMP), while the addition of exogenous 5-bromo-cAMP to macrophage cultures resulted in down-regulation of LPL expression. Using indomethacin (INDO), an inhibitor of cyclo-oxygenase and prostaglandins production, we determined that PGE2 acts as a feedback inhibitor of LPL expression. We found that inhibited secretion of LPL protein in lipopolysaccharide (LPS)-treated macrophages could be restored to control levels by the addition of INDO to the medium. In contrast, INDO did not reverse the inhibition of LPL mRNA induced by LPS. Overall, our results have demonstrated that PGE2 is a potent inhibitor of LPL gene expression and indicated that its action may play an important physiological role in the regulation of LPL gene expression during bacterial infections.",
author = "Desanctis, {J. B.} and L. Varesio and D. Radzioch",
year = "1994",
language = "English",
volume = "81",
pages = "605--610",
journal = "Immunology",
issn = "0019-2805",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Prostaglandins inhibit lipoprotein lipase gene expression in macrophages

AU - Desanctis, J. B.

AU - Varesio, L.

AU - Radzioch, D.

PY - 1994

Y1 - 1994

N2 - In the present investigation of the effects of prostaglandin E2 (PGE2) on lipoprotein lipase (LPL) gene expression in macrophages, we observed that treatment of macrophages with PGE2 increased the levels of adenosine 3',5'- cyclic monophosphate (cAMP), while the addition of exogenous 5-bromo-cAMP to macrophage cultures resulted in down-regulation of LPL expression. Using indomethacin (INDO), an inhibitor of cyclo-oxygenase and prostaglandins production, we determined that PGE2 acts as a feedback inhibitor of LPL expression. We found that inhibited secretion of LPL protein in lipopolysaccharide (LPS)-treated macrophages could be restored to control levels by the addition of INDO to the medium. In contrast, INDO did not reverse the inhibition of LPL mRNA induced by LPS. Overall, our results have demonstrated that PGE2 is a potent inhibitor of LPL gene expression and indicated that its action may play an important physiological role in the regulation of LPL gene expression during bacterial infections.

AB - In the present investigation of the effects of prostaglandin E2 (PGE2) on lipoprotein lipase (LPL) gene expression in macrophages, we observed that treatment of macrophages with PGE2 increased the levels of adenosine 3',5'- cyclic monophosphate (cAMP), while the addition of exogenous 5-bromo-cAMP to macrophage cultures resulted in down-regulation of LPL expression. Using indomethacin (INDO), an inhibitor of cyclo-oxygenase and prostaglandins production, we determined that PGE2 acts as a feedback inhibitor of LPL expression. We found that inhibited secretion of LPL protein in lipopolysaccharide (LPS)-treated macrophages could be restored to control levels by the addition of INDO to the medium. In contrast, INDO did not reverse the inhibition of LPL mRNA induced by LPS. Overall, our results have demonstrated that PGE2 is a potent inhibitor of LPL gene expression and indicated that its action may play an important physiological role in the regulation of LPL gene expression during bacterial infections.

UR - http://www.scopus.com/inward/record.url?scp=0028017715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028017715&partnerID=8YFLogxK

M3 - Article

C2 - 8039811

AN - SCOPUS:0028017715

VL - 81

SP - 605

EP - 610

JO - Immunology

JF - Immunology

SN - 0019-2805

IS - 4

ER -